NASDAQ:HUMA
Humacyte, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.humacyte.comipo date
Dec 01, 2020
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigation...Show More
Earnings
Earnings Release in 16 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus